NCT03820960View on ClinicalTrials.gov

Risk Factors for Thrombosis in Immune Thrombocytopenia

CompletedOBSERVATIONAL
Enrollment

10,039

Participants

Timeline

Start Date

February 1, 2019

Primary Completion Date

February 28, 2021

Study Completion Date

March 31, 2021

Conditions
Immune Thrombocytopenia
Trial Locations (1)

Unknown

University Hospital Toulouse, Toulouse

All Listed Sponsors
lead

University Hospital, Toulouse

OTHER

NCT03820960 - Risk Factors for Thrombosis in Immune Thrombocytopenia | Biotech Hunter | Biotech Hunter